Clinical Trial Update: Botulinum Toxin Type A Block of the Otic Ganglion in Chronic Cluster Headache: Safety Issues [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluating safety of botulinum toxin type A injection blocking the otic ganglion for chronic cluster headache; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cluster Headache

Drugs mentioned

• Botulinum toxin type A (botulinum toxin type A)

Snippet

Sponsor: Norwegian University of Science and Technology | Conditions: Cluster Headache | Phase 1, Phase 2 | Status: COMPLETED